Atos: weak Q1 2024 results, need for fresh funds has already increasedVerisure launches a new term loan; new bonds to followVerallia: Q1 2024 logically weak but the recovery in demand is confirmedAngloAmerican Plc: Takeover offer from BHP Group for the entire share capital>...
Atos : faibles résultats au T1 2024, les besoins de nouveaux fonds a augmentéVerisure lance un nouveau term loan ; des nouvelles obligations suivrontVerallia : T1 2024 logiquement faible mais la reprise de la demande se confirmeAngloAmerican PLC : Offre de rachat sur la totalité du capital par BHP>...
Having flirted with the 495-point mark on Friday, which could have triggered an extension of the correction, the market has rebounded well since then. Our technical analysis highlights a configuration in which we are only at the start of a powerful rally. Target of 622 points for Stoxx 600 index (+11%) by the end of the year confirmed. Prefer banks to insurance companies in the short term. - ...
Après avoir frôlé vendredi la barre des 495 points qui aurait pu déclencher la poursuite de la correction, le marché a ensuite bien rebondi. Notre analyse technique met en lumière une configuration où nous ne serions qu’au début d’un rallye puissant. Objectif 622 points (+11%) d’ici à la fin de l’année confirmé sur le Stoxx 600. Préférer les banques aux assurances à court terme. - ...
>Q1 org growth of -2.6%, above expectations thanks to Tech Foundation - Atos just released its Q1 2024 sales. Q1 2024 revenue stood at € 2,479m, 1.1% above css expectations and -2.8% below our estimates (ODDO BHF: € 2,551m; css: € 2,452m). This implies organic growth at -2.6%, 110bp above css expectations (vs ODDO BHF: -2.3% org; css: -3.7% org.), slowing down sharply vs previous quarter (vs -0.6% org in Q4 2023) due to Eviden weakness. By division, i/Tech Foundations...
>Q1 org growth of -2.6%, above expectations thanks to Tech Foundation - Atos just released its Q1 2024 sales. Q1 2024 revenue stood at € 2,479m, 1.1% above css expectations and -2.8% below our estimates (ODDO BHF: € 2,551m; css: € 2,452m). This implies organic growth at -2.6%, 110bp above css expectations (vs ODDO BHF: -2.3% org; css: -3.7% org.), slowing down sharply vs previous quarter (vs -0.6% org in Q4 2023) due to Eviden weakness. By division, i/Tech Foundations...
Atos reports first quarter 2024 performance Press Release Atos reports first quarter 2024 performance1 Q1 2024 Revenue €2,479m, down -2.6% organically Eviden down -3.9% organically, reflecting continued softness in Americas and the UKTech Foundations down -1.5% organically, reflecting lower scope of work with certain customers in Americas and Central Europe Order entry of €1.6bn for a book-to-bill of 64%, compared with 73% in prior year Eviden book-to-bill at 83%, compared with 79% in prior year, driven by stronger demand in High-Performance ComputingTech Foundations book-to-b...
Atos publie sa performance du premier trimestre 2024 Communiqué de presse Atos publie sa performance1 du premier trimestre 2024 Chiffre d’affaires du T1 2024 : 2 479 m€, en baisse organique de -2,6% Eviden : -3,9% en organique, reflétant la faiblesse des marchés des Amériques et du Royaume-UniTech Foundations : -1,5% en organique, reflétant des réductions de périmètres contractuels pour certains clients en Amériques et Europe Centrale Prise de commandes de 1,6 mds€ pour un ratio de prise de commandes sur chiffre d’affaires à 64% par rapport à 73% l’an dernier Ratio de prise de command...
Nous réitérons notre recommandation Surperformance (conviction Midcap Europe) avec un objectif de cours et des prévisions de résultats relevés. L’optimisme est de rigueur sur les perspectives d’activité, les marges offrent encore un potentiel d’amélioration, le bilan est sous-leveragé, les multiples de valorisation restent attractifs et le fondateur achète des actions. - ...
We reiterate our Outperform recommendation on the stock (European midcap top pick). We have revised up our target price and earnings forecasts. Bright prospects ahead for revenues, still room for margin improvement, the balance sheet is underleveraged, valuation multiples remain attractive and the founder is buying shares. - ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.